On Friday, FMC Corp. (NYSE:FMC)’s shares surged 1.78% to $58.38, as on April 1 a diversified chemical company, declared the company has accomplished the sale of its Alkali Chemicals business to Tronox Limited (TROX) in a transaction valued at $1.64 billion.
FMC anticipates to close the Cheminova attainment in April.
BofA Merrill Lynch and Goldman, Sachs & Co. were FMC’s financial advisors for this transaction. Wachtell, Lipton, Rosen & Katz and Morgan Lewis & Bockius LLP served as FMC’s legal advisors for this transaction.
FMC Corporation, a diversified chemical company, provides solutions, applications, and products for the agricultural, consumer, and industrial markets in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through three segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium.
Hewlett-Packard Company (NYSE:HPQ)’s shares gained 1.77% to $32.11, during the last trading session on Friday, after Hewlett-Packard introduced a new portfolio of HP PageWide XL Printers, offering the fastest large-format production printing accessible in color and black-and-white.
HP PageWide XL Printers do the job of two printers in one single device, providing monochrome and color prints at breakthrough speeds up to 60 percent faster than the fastest monochrome light-emitting diode (LED) printer.
The new printers will enable reprographic houses, print service providers (PSPs), enterprise central reprographic departments (CRDs) and print corners to produce computer-aided design (CAD) drawings and will open new business opportunities with geographic information system (GIS) maps, point-of-sale applications and posters.
Hewlett-Packard Company, together with its auxiliaries, provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses (SMBs), in addition to to the government, health, and education sectors worldwide.
At the end of Friday’s trade, Knowles Corporation (NYSE:KN)’s shares gained 1.77% to $20.13, as Knowles Corporation will issue its first quarter 2015 financial results on April 23, 2015 right away after market close followed by a conference call at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to talk about the results.
Knowles Corporation designs, manufactures, and sells products and components to the mobile communications, consumer electronics, medical technology, telecommunications infrastructure, military, aerospace, and industrial markets worldwide. The company operates in two segments, Mobile Consumer Electronics and Specialty Components.
Finally, The Medicines Company (NASDAQ:MDCO), ended its Friday’s trading session with 1.76% gain, and closed at $28.31, after Medicines Company declared preliminary worldwide net proceed for the first quarter of 2015.
The Company anticipates worldwide net proceed in the range of $125 million to $130 million for the first quarter of 2015, which reflects a 29% to 26% decrease from the $177.2 million in worldwide net proceed stated for the first quarter of 2014. The decrease in worldwide net proceed is a result of lower worldwide net proceed from sales of Angiomax® (bivalirudin)/Angiox® (bivalirudin), which the Company anticipates to be in the range of $97 million to $105 million contrast to $155.7 million in the first quarter of 2014.
”We believe the decline in first-quarter worldwide net proceed from sales of Angiomax reflects our customers’ current uncertainty regarding the product’s patent exclusivity in the United States past June 2015,” said Clive Meanwell, MD, PhD, Chairman and CEO of The Medicines Company. “We appreciate our customers’ concerns about managing their pharmaceutical inventories. At the same time, we are happy to see growth in our other products year-on-year and we expect this to continue as we diversify our sources of proceed. We will continue to provide our hospital customers with the high level of product support they have come to expect from us for all of our brands.”
The Company anticipates to release its final results for the first quarter of 2015 on Tuesday, May 5th, 2015 and to hold a conference call at 8:30 a.m. Eastern Time to talk about its financial results and other operational developments.
The Medicines Company’s purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: serious infectious disease care, acute cardiovascular care and surgery and perioperative care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers recently in Parsippany, NJ, USA and Zurich, Switzerland.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
